1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 61-80 of 150 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
61Jun-2016Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.Yao, Jun; Caballero, Otavia L; Huang, Ying; Lin, Calvin; Rimoldi, Donata; Behren, Andreas; Cebon, Jonathan S ; Hung, Mien-Chie; Weinstein, John N; Strausberg, Robert L; Zhao, Qi
6210-May-2016Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy.Bowyer, S; Prithviraj, Prashanth; Lorigan, P; Larkin, J; McArthur, G; Atkinson, V; Millward, M; Khou, M; Diem, S; Ramanujam, S; Kong, B; Liniker, E; Guminski, A; Parente, P; Andrews, M C; Parakh, S ; Cebon, Jonathan S ; Long, G V; Carlino, M S; Klein, O 
63Apr-2016First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors.Dienstmann, Rodrigo; Lassen, Ulrik; Cebon, Jonathan S ; Desai, Jayesh; Brown, Michael P; Evers, Stefan; Su, Fei; Zhang, Weijiang; Boisserie, Frederic; Lestini, Brian; Schostack, Kathleen; Meresse, Valerie; Tabernero, Josep
6410-Mar-2016Overall survival and durable responses in patients with BRAF V600–mutant metastatic melanoma receiving dabrafenib combined with trametinibLong, Georgina V; Weber, Jeffrey s; Infante, Jeffrey R; Kim, Kevin B; Daud, Adil; Gonzalez, Rene; Sosman, Jeffrey A; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan S ; Kefford, Richard F; Lawrence, Donald P; Kudchadkar, Ragini; Burris, Howard A; Falchook, Gerald S; Algazi, Alain; Lewis, Karl; Puzanov, Igor; Ibrahim, Nageatte; Sun, Peng; Cunningham, Elizabeth; Kline, Amy S; Del Buono, Heather; McDowell, Diane Opatt; Patel, Kiran; Flaherty, Keith T
65Mar-2016Clinicopathological characteristics associated with BRAF(K601E) and BRAF(L597) mutations in melanoma.Voskoboynik, Mark; Mar, Victoria; Mailer, Sonia; Colebatch, Andrew; Fennessy, Anne; Logan, Aleksandra; Hewitt, Chelsee; Cebon, Jonathan S ; Kelly, John; McArthur, Grant
6622-Feb-2016Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.Jayachandran, Aparna; Lo, Pu-Han; Chueh, Anderly C; Prithviraj, Prashanth; Molania, Ramyar; Davalos-Salas, Mercedes; Anaka, Matthew; Walkiewicz, Marzena; Cebon, Jonathan S ; Behren, Andreas
6716-Feb-2016Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanomaWoods, K; Knights, AJ; Anaka, M; Schittenhelm, RB; Purcell, AW; Behren, Andreas; Cebon, Jonathan S 
68Feb-2016Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro.Gedye, Craig; Cardwell, Tracy; Dimopoulos, Nektaria; Tan, Bee Shin; Jackson, Heather M; Svobodová, Suzanne; Anaka, Matthew; Behren, Andreas; Maher, Christopher; Hofmann, Oliver; Hide, Winston; Caballero, Otavia; Davis, Ian D; Cebon, Jonathan S 
69Jan-2016Capture and on-chip analysis of melanoma cells using tunable surface shear forcesTsao, Simon Chang-Hao; Vaidyanathan, Ramanathan; Dey, Shuvashis; Carrascosa, Laura G; Christophi, Christopher ; Cebon, Jonathan S ; Shiddiky, Muhammad JA; Behren, Andreas; Trau, Matt
701-Dec-2015Cellular mechanisms underlying complete hematological response of chronic myeloid leukemia to BRAF and MEK1/2 inhibition in a patient with concomitant metastatic melanomaAndrews, Miles C; Turner, Natalie; Boyd, Janis; Roberts, Andrew W; Grigg, Andrew P ; Behren, Andreas; Cebon, Jonathan S 
71Dec-2015Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesWilmott, James S; Field, Matthew A; Johansson, Peter A; Kakavand, Hojabr; Shang, Ping; De Paoli-Iseppi, Ricardo; Vilain, Ricardo E; Pupo, Gulietta M; Tembe, Varsha; Jakrot, Valerie; Shang, Catherine A; Cebon, Jonathan S ; Shackleton, Mark; Fitzgerald, Anna; Thompson, John F; Hayward, Nicholas K; Mann, Graham J; Scolyer, Richard A
7222-Jun-2015Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.Tsao, Simon Chang-Hao; Weiss, Jonathan; Hudson, Christopher; Christophi, Christopher ; Cebon, Jonathan S ; Behren, Andreas; Dobrovic, Alexander 
7310-Apr-2015Pregnancy Associated Plasma Protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion.Prithviraj, Prashanth; Anaka, Matthew; McKeown, Sonja J; Permezel, Michael; Walkiewicz, Marzena; Cebon, Jonathan S ; Behren, Andreas; Jayachandran, Aparna
7416-Feb-2015Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells.Jayachandran, Aparna; McKeown, Sonja J; Woods, Briannyn L; Prithviraj, Prashanth; Cebon, Jonathan S 
757-Feb-2015Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma.Klein, Oliver ; Davis, Ian D; McArthur, Grant A; Chen, Li; Haydon, Andrew; Parente, Phillip; Dimopoulos, Nektaria; Jackson, Heather M; Xiao, Kun; Maraskovsky, Eugene; Hopkins, Wendie; Stan, Rodica; Chen, Weisan; Cebon, Jonathan S 
7620-Jan-2015Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.Wong, Stephen Q; Behren, Andreas; Mar, Victoria J; Woods, Katherine; Li, Jason; Sheppard, Karen E; Wolfe, Rory; Kelly, John; Cebon, Jonathan S ; Dobrovic, Alexander ; McArthur, Grant A
771-Jan-2015The role of circulating microRNA in hepatocellular carcinoma.Chang-Hao Tsao, Simon; Behren, Andreas; Cebon, Jonathan S ; Christophi, Christopher 
7817-Dec-2014Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells.Woods, Katherine; Pasam, Anupama; Jayachandran, Aparna; Andrews, Miles C; Cebon, Jonathan S 
7910-Nov-2014Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma.Parakh, S ; Murphy, C; Lau, D ; Cebon, Jonathan S ; Andrews, Miles C
806-Oct-2014Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor.Johnson, Douglas B; Flaherty, Keith T; Weber, Jeffrey S; Infante, Jeffrey R; Kim, Kevin B; Kefford, Richard F; Hamid, Omid; Schuchter, Lynn; Cebon, Jonathan S ; Sharfman, William H; McWilliams, Robert R; Sznol, Mario; Lawrence, Donald P; Gibney, Geoffrey T; Burris, Howard A; Falchook, Gerald S; Algazi, Alain; Lewis, Karl; Long, Georgina V; Patel, Kiran; Ibrahim, Nageatte; Sun, Peng; Little, Shonda; Cunningham, Elizabeth; Sosman, Jeffrey A; Daud, Adil; Gonzalez, Rene